These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2533 related articles for article (PubMed ID: 27056547)

  • 1. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
    Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
    Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of miR-31 and miR-375 expression is associated with clinical outcomes in oral carcinoma.
    Siow MY; Ng LP; Vincent-Chong VK; Jamaludin M; Abraham MT; Abdul Rahman ZA; Kallarakkal TG; Yang YH; Cheong SC; Zain RB
    Oral Dis; 2014 May; 20(4):345-51. PubMed ID: 23651447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.
    Manikandan M; Deva Magendhra Rao AK; Rajkumar KS; Rajaraman R; Munirajan AK
    J Oral Pathol Med; 2015 Nov; 44(10):792-800. PubMed ID: 25482863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Analysis and MicroRNA Expression Profiling Identified Seven miRNAs Associated With Progression of Oral Squamous Cell Carcinoma.
    Yan ZY; Luo ZQ; Zhang LJ; Li J; Liu JQ
    J Cell Physiol; 2017 Aug; 232(8):2178-2185. PubMed ID: 27935034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways.
    Fukumoto I; Hanazawa T; Kinoshita T; Kikkawa N; Koshizuka K; Goto Y; Nishikawa R; Chiyomaru T; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Br J Cancer; 2015 Mar; 112(5):891-900. PubMed ID: 25668004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNAs expression of oral squamous cell carcinoma patients: Validation of two putative biomarkers.
    Chamorro Petronacci CM; Pérez-Sayáns M; Padín Iruegas ME; Suárez Peñaranda JM; Lorenzo Pouso AI; Blanco Carrión A; García García A
    Medicine (Baltimore); 2019 Mar; 98(13):e14922. PubMed ID: 30921188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of stem cell-regulating miRNAs in oral cavity and oropharynx squamous cell carcinoma.
    Brito BL; Lourenço SV; Damascena AS; Kowalski LP; Soares FA; Coutinho-Camillo CM
    J Oral Pathol Med; 2016 Oct; 45(9):647-654. PubMed ID: 26841253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-generation Sequencing for microRNA Profiling: MicroRNA-21-3p Promotes Oral Cancer Metastasis.
    Tseng HH; Tseng YK; You JJ; Kang BH; Wang TH; Yang CM; Chen HC; Liou HH; Liu PF; Ger LP; Tsai KW
    Anticancer Res; 2017 Mar; 37(3):1059-1066. PubMed ID: 28314265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unveiling the Potential of Serum MiR-483-5p: A Promising Diagnostic and Prognostic Biomarker in OLP and OSCC Patients by
    Soltaninezhad P; Arab F; Mohtasham N; FakherBaheri M; Kavishahi NN; Aghaee-Bakhtiari SH; Zare-Mahmoodabadi R; Pakfetrat A; Taban KI; Mohajertehran F
    Curr Pharm Des; 2024; 30(4):310-322. PubMed ID: 38310566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-194 regulated AGK and inhibited cell proliferation of oral squamous cell carcinoma by reducing PI3K-Akt-FoxO3a signaling.
    Chi H
    Biomed Pharmacother; 2015 Apr; 71():53-7. PubMed ID: 25960215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling.
    Yang MH; Lin BR; Chang CH; Chen ST; Lin SK; Kuo MY; Jeng YM; Kuo ML; Chang CC
    Oncogene; 2012 May; 31(19):2401-11. PubMed ID: 21927029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B.
    Li L; Ma HQ
    Mol Med Rep; 2015 Aug; 12(2):3156-62. PubMed ID: 25955794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low expression of miR-let-7a promotes cell growth and invasion through the regulation of c-Myc in oral squamous cell carcinoma.
    Luo C; Zhang J; Zhang Y; Zhang X; Chen Y; Fan W
    Cell Cycle; 2020 Aug; 19(15):1983-1993. PubMed ID: 32594835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
    Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
    J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
    Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
    J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
    Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
    Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.
    Romani C; Salviato E; Paderno A; Zanotti L; Ravaggi A; Deganello A; Berretti G; Gualtieri T; Marchini S; D'Incalci M; Mattavelli D; Piazza C; Bossi P; Romualdi C; Nicolai P; Bignotti E
    Theranostics; 2021; 11(6):2987-2999. PubMed ID: 33456584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor.
    Lin SC; Kao SY; Chang JC; Liu YC; Yu EH; Tseng SH; Liu CJ; Chang KW
    Oncotarget; 2016 Sep; 7(38):61355-61365. PubMed ID: 27542258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of miR-455-5p by the TGF-β-SMAD signalling axis promotes the proliferation of oral squamous cancer cells by targeting UBE2B.
    Cheng CM; Shiah SG; Huang CC; Hsiao JR; Chang JY
    J Pathol; 2016 Sep; 240(1):38-49. PubMed ID: 27235675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 127.